Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Symphonix v. Soundtec

This article was originally published in The Gray Sheet

Executive Summary

Response to Nov. 27 Symphonix suit alleging misappropriation of trade secrets maintains that an implantable hearing device developed for Soundtec by Jack Hough, MD, uses a unique design and is different from the technology Hough helped develop for Symphonix when he worked for Central Ear Research Institute (CERI). Symphonix' suit is therefore "groundless," Soundtec claims in its Dec. 6 response (1"The Gray Sheet" Dec 3, 2001, p. 20)...

You may also be interested in...



Sulzer Medica Optimistic That Mediation Agreement Will Prevent Bankruptcy

An agreement attempting to resolve the suit between Sulzer Orthopedics and injured parties through a third party signals a recognition by plaintiffs that the litigation could bankrupt parent Sulzer Medica, according to the Winterhur, Switzerland company

Pharma Can Pursue Claims Against Providers For 340B Duplicate Discounts In Medicaid Managed Care, HRSA Says

The statement, which is part of a final rule on the 340B administrative dispute resolution process, could facilitate manufacturer efforts to seek repayments from hospitals in such cases.

The Aspirin Test For AI?

US FDA Commissioner Robert Califf tells Congress that regulators don’t have to know how artificial intelligence works in medicine, but must make very sure it actually does work.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT015828

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel